Gamma-glutamylcysteine synthetase deficiency
MONDO:0009259A disorder that is principally characterized by hemolytic anemia, (usually rather mild), however, the presence of neurological symptoms has also been reported.
Also known as: anemia, congenital, nonspherocytic hemolytic, 7, gamma-glutamylcysteine synthetase deficiency, hemolytic anaemia due to, gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to, glutamate-cysteine ligase deficiency, hemolytic anaemia due to gamma-glutamylcysteine synthetase deficiency, inborn error of glutamate-cysteine ligase activity, inborn glutamate-cysteine ligase activity disorder, rare inborn error of glutamate-cysteine ligase activity
20 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New blood treatment could block zika in transfusions
Disease control OngoingThis study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New cord blood matching method could expand transplant access for blood cancer patients
Disease control OngoingThis study tests a new approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. Patients receive a combination of umbilical cord blood and stem cells from a family member, with the cord blood chosen based on specific genetic markers rather than …
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC